Uptake of the human papillomavirus-vaccination within the free-of-charge childhood vaccination programme in Denmark

Vaccine

Volumn 29, Issue 52, 2011, Pages 9663-9667

  Widgren, Katarina ^a,b   Simonsen, Jacob ^b   Valentiner Branth, Palle ^b   Mølbak, Kåre ^b  

^a EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

Papillomavirus vaccines; Patient acceptance of health care; Registries; Survival analysis; Vaccination

Indexed keywords

WART VIRUS VACCINE;

ARTICLE; CHILD; DEMOGRAPHY; DENMARK; FEMALE; HUMAN; MATERNAL AGE; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; SCHOOL CHILD; SIBLING; SURVIVAL; UTERINE CERVIX CANCER; VACCINATION; WART VIRUS;

CHILD; DENMARK; FEMALE; HEALTH POLICY; HUMANS; IMMUNIZATION SCHEDULE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; VACCINATION;

EID: 82555176577     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.10.021     Document Type: Article

References (29)

1. Reduction in the risk of cervical cancer by vaccination against human papillomavirus (HPV) - a health technology assessment 2007, National Board of Health, Available from:. http://www.sst.dk/publ/Publ2007/MTV/HPV/HPV_vaccination_smfatn_en.pdf.
2. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189:12-19.
3. Ault K.A. Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials. Lancet 2007, 369:1861-1868.
4. Paavonen J., Naud P., Salmeron J., Wheeler C.M., Chow S.N., Apter D., et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009, 374:301-314.
5. Glismann S.O., Christiansen A.H., Valentiner-Branth P., Andersen P.H. Human papillomavirus vaccine in the childhood vaccination programme. EpiNews 2008, 3:5. Available from:. http://www.ssi.dk/English/News/EPI-NEWS/2008.aspx.
6. National Board of Health. Invitation til vaccination mod livmoderhalskræft til piger født i 1996 [Invitation to vaccination against cervical cancer for girls born in 1996]; 2009 [cited 2011 19 January]. Available from: http://www.sst.dk/Nyhedscenter/Nyheder/2009/HPV_vaccination_januar2009.aspx.
7. Mortensen G.L. Drivers and barriers to acceptance of human-papillomavirus vaccination among young women: a qualitative and quantitative study. BMC Public Health 2010, 10:68.
8. Brewer N.T., Fazekas K.I. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med 2007, 45:107-114.
9. Zimet G.D., Mays R.M., Winston Y., Kee R., Dickes J., Su L. Acceptability of human papillomavirus immunization. J Womens Health Gend Based Med 2000, 9:47-50.
10. Friedman A.L., Shepeard H. Exploring the knowledge, attitudes, beliefs, and communication preferences of the general public regarding HPV: findings from CDC focus group research and implications for practice. Health Educ Behav 2007, 34:471-485.
11. Olshen E., Woods E.R., Austin S.B., Luskin M., Bauchner H. Parental acceptance of the human papillomavirus vaccine. J Adolesc Health 2005, 37:248-251.
12. Marlow L.A., Waller J., Wardle J. Parental attitudes to pre-pubertal HPV vaccination. Vaccine 2007, 25:1945-1952.
13. Dahlstrom L.A., Tran T.N., Lundholm C., Young C., Sundstrom K., Sparen P. Attitudes to HPV vaccination among parents of children aged 12-15 years - a population-based survey in Sweden. Int J Cancer 2010, 126:500-507.
14. Davis K., Dickman E.D., Ferris D., Dias J.K. Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. J Low Genit Tract Dis 2004, 8:188-194.
15. Humiston S.G., Rosenthal S.L. Challenges to vaccinating adolescents: vaccine implementation issues. Pediatr Infect Dis J 2005, 24:S134-S140.
16. Larson H.J., Cooper L.Z., Eskola J., Katz S.L., Ratzan S. Addressing the vaccine confidence gap. Lancet 2011, 378:526-535.
17. Pedersen C.B., Gotzsche H., Moller J.O., Mortensen P.B. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull 2006, 53:441-449.
18. Hviid A. Postlicensure epidemiology of childhood vaccination: the Danish experience. Expert Rev Vaccines 2006, 5:641-649.
19. Michelsen S.I., Kastanje M., Flachs E.M., Søndergaard G., Biering-Sørensen S., Madsen M., et al. Evaluering af de forebyggende børneundersøgelser i almen praksis 2007, National Board of Health, National Institute of Public Health, University of Southern Denmark, Available from:. http://www.si-folkesundhed.dk/upload/2698_-_evaluering_af_de_forebyggende_b%25C3%25B8renunders%25C3%25B8gelser_i_almen_praksis_ii.pdf.
20. Valentiner-Branth P., Andersen P.H., Simonsen J. DTaP-IPV/Hib vaccination coverage. EpiNews 2010, 9. Available from:. http://www.ssi.dk/English/News/EPI-NEWS/2010/No%25209%2520-%25202010.aspx.
21. Valentiner-Branth P., Glismann S.O., Christiansen A.H., Simonsen J. MMR vaccination coverage. EpiNews 2010, 10. Available from:. http://www.ssi.dk/English/News/EPI-NEWS/2010/No%252010%2520-%25202010.aspx.
22. Ethelberg S., Simonsen J., Gerner-Smidt P., Olsen K.E., Molbak K. Spatial distribution and registry-based case-control analysis of Campylobacter infections in Denmark, 1991-2001. Am J Epidemiol 2005, 162:1008-1015.
23. Widgren K., Valentiner-Branth P., Andersen P.H., Glismann S.O., Simonsen J. HPV vaccination: coverage. EpiNews 2010, 6. Available from:. http://www.ssi.dk/English/News/EPI-NEWS/2010/No%25206%2520-%25202010.aspx.
24. Valentiner-Branth P., Widgren K., Andersen P.H., Glismann S.O., Simonsen J. HPV vaccination, coverage 2010. EpiNews 2011, 18. Available from:. http://www.ssi.dk/English/News/EPI-NEWS/2011/No%252018%2520-%25202011.aspx.
25. årsrapport for HPV-vaksine i barnevaksinasjonsprogrammet 2009/2010 2011, Norwegian Institute of Public Health, Available from:. http://www.fhi.no/dokumenter/9b6754addc.pdf.
26. Annual HPV vaccine uptake in England: 2008/09 2010, Department of Health, London, Available from:. http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/@ps/documents/digitalasset/dh_111676.pdf.
27. Limia A., Pachon I. Coverage of human papillomavirus vaccination during the first year of its introduction in Spain. Euro Surveill 2011, 16.
28. Rondy M., van Lier A., van de Kassteele J., Rust L., de Melker H. Determinants for HPV vaccine uptake in the Netherlands: a multilevel study. Vaccine 2010, 28:2070-2075.
29. Nohr B., Munk C., Tryggvadottir L., Sparen P., Tran T.N., Nygard M., et al. Awareness of human papillomavirus in a cohort of nearly 70,000 women from four Nordic countries. Acta Obstet Gynecol Scand 2008, 87:1048-1054.